Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma

Por Tavanti, E, Sero, V, Vella, S, Fanelli, M, Michelacci, F, Landuzzi, L, Magagnoli, G, Versteeg, R, Picci, P, Hattinger, C M, Serra, M
Publicado em 2013

Prognostic impact of chromosomal aberrations in Ewing tumours

Por Hattinger, C M, Pötschger, U, Tarkkanen, M, Squire, J, Zielenska, M, Kiuru-Kuhlefelt, S, Kager, L, Thorner, P, Knuutila, S, Niggli, F K, Ambros, P F, Gadner, H, Betts, D R
Publicado em 2002